Fennec (FENC) Gets CRL From FDA for Pedmark, Stock Down

Fennec (FENC) suffers a setback again with a CRL for its new drug application (NDA) for Pedmark. Shares are down in pre-market trading.

from Entrepreneur: Latest Articles Fennec (FENC) suffers a setback again with a CRL for its new drug application (NDA) for Pedmark. Shares are down in pre-market trading. https://ift.tt/eA8V8J December 01, 2021 at 12:20AMhttps://https://ift.tt/31geh5o